FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 94 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $305,000 | +33.8% | 50,000 | -50.0% | 0.00% | 0.0% |
| Q1 2020 | $228,000 | -0.9% | 100,000 | +100.0% | 0.00% | 0.0% |
| Q4 2019 | $230,000 | -61.9% | 50,000 | +11.1% | 0.00% | -50.0% |
| Q1 2019 | $603,000 | +150.2% | 45,000 | +221.4% | 0.00% | +100.0% |
| Q1 2018 | $241,000 | -21.5% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $307,000 | -58.3% | 14,000 | -22.2% | 0.00% | -66.7% |
| Q3 2017 | $736,000 | +62.8% | 18,000 | +20.0% | 0.00% | +50.0% |
| Q2 2017 | $452,000 | +4.1% | 15,000 | +25.0% | 0.00% | 0.0% |
| Q1 2017 | $434,000 | -42.3% | 12,000 | -20.0% | 0.00% | -50.0% |
| Q4 2016 | $752,000 | -4.4% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $787,000 | +32.3% | 15,000 | +4.2% | 0.00% | +33.3% |
| Q2 2016 | $595,000 | +1.7% | 14,400 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $585,000 | -34.6% | 14,400 | -33.2% | 0.00% | -25.0% |
| Q4 2015 | $894,000 | – | 21,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|